Accelerated Hydrolysis System
US-2019381508-A1 · Dec 19, 2019 · US
US9855536B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9855536-B2 |
| Application number | US-201313891524-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 10, 2013 |
| Priority date | Apr 4, 2006 |
| Publication date | Jan 2, 2018 |
| Grant date | Jan 2, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Apparatus and methods for generating foam are disclosed. The inventions can be used for generating foam for sclerotherapy. A foaming element can be agitated within a foaming chamber by a drive unit that does not touch the foaming element, but actuates it from outside the foaming chamber. The foaming element and drive unit can be magnetically coupled. A syringe can be used to form a foaming chamber.
Opening claim text (preview).
What is claimed is: 1. A method of preparing vascular treatment agent, said method comprising: contactlessly moving an agitator having at least one flow passage therethrough within a volume of vascular treatment agent disposed within a chamber, wherein the agitator is contactlessly coupled to a drive unit external to the chamber; and foaming said vascular treatment agent by forcing the vascular treatment agent through the at least one flow passage as the agitator is moved within the chamber by the drive unit. 2. The method of claim 1 , further comprising injecting said foamed vascular treatment agent into a blood vessel of a patient. 3. The method of claim 2 , wherein said agent comprises a sclerosant. 4. The method of claim 3 , wherein said blood vessel comprises a vein. 5. The method of claim 2 , wherein the vascular treatment agent reduces the patency of said blood vessel after injection into the blood vessel. 6. The method of claim 1 , wherein moving said agitator comprises linearly moving said agitator. 7. The method of claim 6 , wherein said chamber has a longitudinal axis, and linearly moving said agitator comprises linearly reciprocating said agitator along said longitudinal axis. 8. The method of claim 1 , wherein moving said agitator comprises rotating said agitator. 9. The method of claim 8 , wherein said chamber has a longitudinal axis, and rotating said agitator comprises rotating said agitator about said longitudinal axis. 10. The method of claim 1 , wherein contactlessly moving said agitator comprises magnetically moving said agitator. 11. The method of claim 1 , wherein contactlessly moving said agitator comprises electrostatically moving said agitator. 12. The method of claim 1 , wherein said chamber comprises a syringe. 13. The method of claim 12 , wherein the drive unit comprises a magnetic drive unit, wherein the agitator is magnetically coupled to the magnetic drive unit, and wherein contactlessly moving said agitator within said chamber comprises contactlessly moving said agitator within said syringe with said magnetic drive unit. 14. The method of claim 13 , further comprising receiving said syringe in said magnetic drive unit. 15. The method of claim 1 , wherein the agitator is magnetically coupled to the drive unit, the drive unit being movable external to the chamber, and wherein the agitator is contactlessly moved by movement of the drive unit relative to the chamber. 16. The method of claim 15 , wherein the chamber is in a syringe that is received in the drive unit. 17. The method of claim 1 , wherein foaming said vascular treatment agent by forcing the vascular treatment agent through the at least one flow passage as the agitator is moved within the chamber comprises rotating a paddle of the agitator within the chamber to force the vascular treatment agent through a plurality of flow passages formed in the paddle. 18. The method of claim 17 , wherein the agitator and the paddle are rotated about a longitudinal axis, the paddle extending from a surface of the agitator parallel to the longitudinal axis. 19. The method of claim 17 , wherein the plurality of flow passages comprise more than 20 flow passages formed in the paddle, each flow passage of the more than 20 flow passages having a diameter less than 0.010 inches. 20. A method of preparing vascular treatment agent, the method comprising contactlessly moving an agitator linearly within a volume of vascular treatment agent disposed within a chamber, the agitator having at least one flow passage therethrough; and foaming said vascular treatment agent by forcing the vascular treatment agent through the at least one flow passage as the agitator is moved within the chamber. 21. A method of preparing vascular treatment agent, the method comprising contactlessly and magnetically moving an agitator having at least one flow passage therethrough within a volume of vascular treatment agent disposed within a chamber; and foaming the vascular treatment agent by forcing the vascular treatment agent through the at least one flow passage as the agitator is moved within the chamber.
Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle · CPC title
Operations & Transport · mapped topic
Operations & Transport · mapped topic
characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula · CPC title
Caps for syringes without needle · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.